KalVista Pharmaceuticals, Inc.
KALV
$27.00
$0.010.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 07/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 285.03M | 300.21M | 309.16M | 191.47M | -- |
| Total Receivables | 17.33M | 11.30M | 7.12M | 6.50M | -- |
| Inventory | 4.00M | 3.43M | 458.00K | -- | -- |
| Prepaid Expenses | 7.85M | 5.20M | 8.49M | 7.93M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 314.21M | 320.15M | 325.23M | 205.90M | 241.69M |
|
|
|||||
| Total Current Assets | 314.21M | 320.15M | 325.23M | 205.90M | 241.69M |
| Net Property, Plant & Equipment | 12.26M | 12.86M | 12.29M | 7.23M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.45M | 2.37M | 2.42M | 2.38M | -- |
| Total Assets | 328.92M | 335.38M | 339.93M | 215.51M | 250.77M |
|
|
|||||
| Total Accounts Payable | 8.05M | 8.27M | 8.07M | 5.87M | -- |
| Total Accrued Expenses | 25.08M | 27.06M | 20.77M | 18.97M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.92M | 15.19M | 4.72M | 2.12M | -- |
| Total Finance Division Other Current Liabilities | 9.77M | 6.84M | 11.51M | 11.41M | -- |
| Total Other Current Liabilities | 9.77M | 6.84M | 11.51M | 11.41M | -- |
| Total Current Liabilities | 60.82M | 57.36M | 45.07M | 38.38M | 45.17M |
|
|
|||||
| Total Current Liabilities | 60.82M | 57.36M | 45.07M | 38.38M | 45.17M |
| Long-Term Debt | 255.98M | 258.29M | 268.74M | 132.32M | 105.88M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.41M | 10.73M | 9.13M | 4.02M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 21.36M | 11.71M | -- | -- | -- |
| Total Liabilities | 348.57M | 338.09M | 322.93M | 174.72M | 155.38M |
|
|
|||||
| Common Stock & APIC | 773.65M | 767.11M | 762.83M | 760.44M | -- |
| Retained Earnings | -786.18M | -762.69M | -739.10M | -713.27M | -653.17M |
| Treasury Stock & Other | -7.12M | -7.13M | -6.73M | -6.39M | -- |
| Total Common Equity | -19.65M | -2.71M | 17.00M | 40.79M | 95.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -19.65M | -2.71M | 17.00M | 40.79M | 95.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -19.65M | -2.71M | 17.00M | 40.79M | -- |
|
|
|||||